Advertisement
Screener

Harrow, Inc. (HROW) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Harrow, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities

Harrow, Inc. (HROW) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $11.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-10

  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $8.54M.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $3.38M.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $22.44M, a 27.76% decline year-over-year.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$3.04M, a 198.96% decline year-over-year.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$4.61M, a 112.29% decline from fiscal 2024.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $37.50M, a 17.94% increase from fiscal 2023.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $31.80M, a 3307.82% increase from fiscal 2022.
  • Harrow, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $933.00K, a 46.07% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 0 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 167 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 170 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 173 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 176 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 182 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 185 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 188 month
2026-06-30$8.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$11.92M
10-Q · filed 2026-08-10
$34.36M
derived: sum of 3 quarters · filed 2026-08-10
$31.32M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$3.38M
10-Q · filed 2026-05-11
$25.82M
derived: sum of 2 quarters · filed 2026-05-11
$22.78M
derived: sum of 3 quarters · filed 2026-05-11
$9.87M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$22.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$19.40M
derived: sum of 2 quarters · filed 2026-03-02
$6.49M
derived: sum of 3 quarters · filed 2026-08-10
-$4.61M
10-K · filed 2026-03-02
2025-09-30-$3.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$15.95M
derived: sum of 2 quarters · filed 2026-08-10
-$27.05M
10-Q · filed 2025-11-10
$4.02M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$12.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$24.01M
10-Q · filed 2026-08-10
$7.06M
derived: sum of 3 quarters · filed 2026-08-10
$10.13M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$11.10M
10-Q · filed 2026-05-11
$19.97M
derived: sum of 2 quarters · filed 2026-05-11
$23.04M
derived: sum of 3 quarters · filed 2026-05-11
$35.34M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$31.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$34.14M
derived: sum of 2 quarters · filed 2026-03-02
$46.44M
derived: sum of 3 quarters · filed 2026-03-02
$37.50M
10-K · filed 2026-03-02
2024-09-30$3.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$15.37M
derived: sum of 2 quarters · filed 2025-11-10
$6.43M
10-Q · filed 2025-11-10
$36.64M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30$12.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$3.36M
10-Q · filed 2025-08-11
$33.57M
derived: sum of 3 quarters · filed 2026-03-02
$31.57M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$8.94M
10-Q · filed 2025-05-08
$21.27M
derived: sum of 2 quarters · filed 2026-03-02
$19.27M
derived: sum of 3 quarters · filed 2026-03-02
$23.07M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31$30.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$28.21M
derived: sum of 2 quarters · filed 2026-03-02
$32.01M
derived: sum of 3 quarters · filed 2026-03-02
$31.80M
10-K · filed 2026-03-02
2023-09-30-$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.80M
derived: sum of 2 quarters · filed 2024-11-14
$1.58M
10-Q · filed 2024-11-14
$983.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$3.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$3.58M
10-Q · filed 2024-08-07
$2.98M
derived: sum of 3 quarters · filed 2024-08-07
$2.06M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$212.00K
10-Q · filed 2024-05-13
-$813.00K
derived: sum of 2 quarters · filed 2024-05-13
-$1.73M
derived: sum of 3 quarters · filed 2024-05-13
$352.00K
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$601.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$1.52M
derived: sum of 2 quarters · filed 2024-03-19
$564.00K
derived: sum of 3 quarters · filed 2024-03-19
$933.00K
10-K · filed 2024-03-19
$1.84M
10-K · filed 2023-03-23
2022-09-30-$920.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$1.17M
derived: sum of 2 quarters · filed 2023-11-13
$1.53M
10-Q · filed 2023-11-13
$281.00K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.45M
10-Q · filed 2023-08-09
$1.20M
derived: sum of 3 quarters · filed 2023-08-09
$3.16M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$369.00K
10-Q · filed 2023-05-11
-$884.00K
derived: sum of 2 quarters · filed 2023-05-11
$1.07M
derived: sum of 3 quarters · filed 2023-05-11
$994.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$704.00K
derived: sum of 2 quarters · filed 2023-03-23
$625.00K
derived: sum of 3 quarters · filed 2023-03-23
$1.73M
10-K · filed 2023-03-23
2021-09-30$1.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$1.88M
derived: sum of 2 quarters · filed 2022-11-14
$2.98M
10-Q · filed 2022-11-14
$883.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$79.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.03M
10-Q · filed 2022-08-09
-$1.07M
derived: sum of 3 quarters · filed 2022-08-09
-$1.38M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.10M
10-Q · filed 2022-05-05
-$995.00K
derived: sum of 2 quarters · filed 2022-05-05
-$1.30M
derived: sum of 3 quarters · filed 2022-05-05
-$3.21M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$2.40M
derived: sum of 2 quarters · filed 2022-03-10
-$4.32M
derived: sum of 3 quarters · filed 2022-03-10
-$4.66M
10-K · filed 2022-03-10
2020-09-30-$302.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$2.22M
derived: sum of 2 quarters · filed 2021-11-09
-$2.56M
10-Q · filed 2021-11-09
-$2.93M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$1.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$2.25M
10-Q · filed 2021-08-10
-$2.63M
derived: sum of 3 quarters · filed 2021-08-10
-$1.74M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31-$337.00K
10-Q · filed 2021-05-11
-$716.00K
derived: sum of 2 quarters · filed 2021-05-11
$175.00K
derived: sum of 3 quarters · filed 2021-05-11
$847.00K
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$379.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
$512.00K
derived: sum of 2 quarters · filed 2021-03-08
$1.18M
derived: sum of 3 quarters · filed 2021-03-08
$1.34M
10-K · filed 2021-03-08
2019-09-30$891.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.56M
derived: sum of 2 quarters · filed 2020-11-09
$1.72M
10-Q · filed 2020-11-09
$1.93M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$672.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$830.00K
10-Q · filed 2020-08-10
$1.04M
derived: sum of 3 quarters · filed 2020-08-10
$2.31M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$158.00K
10-Q · filed 2020-05-11
$370.00K
derived: sum of 2 quarters · filed 2020-05-11
$1.64M
derived: sum of 3 quarters · filed 2020-05-11
$2.42M
derived: sum of 4 quarters · filed 2020-05-11
2019-01-02$388.00K
10-Q · filed 2019-05-09
2018-12-31$212.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$1.48M
derived: sum of 2 quarters · filed 2020-03-13
$2.26M
derived: sum of 3 quarters · filed 2020-03-13
$2.37M
10-K · filed 2020-03-13
2018-09-30$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$2.05M
derived: sum of 2 quarters · filed 2019-11-13
$2.15M
10-Q · filed 2019-11-13
$2.00M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$779.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$885.00K
10-Q · filed 2019-08-14
$734.00K
derived: sum of 3 quarters · filed 2019-08-14
$1.43M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$106.00K
10-Q · filed 2019-05-09
-$45.00K
derived: sum of 2 quarters · filed 2019-05-09
$646.00K
derived: sum of 3 quarters · filed 2019-05-09
$88.00K
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$151.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$540.00K
derived: sum of 2 quarters · filed 2019-03-12
-$18.00K
derived: sum of 3 quarters · filed 2019-03-12
$346.00K
10-K · filed 2019-03-12
2017-09-30$691.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$133.00K
derived: sum of 2 quarters · filed 2018-11-13
$497.00K
10-Q · filed 2018-11-13
$364.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$558.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$194.00K
10-Q · filed 2018-08-06
-$327.00K
derived: sum of 3 quarters · filed 2018-08-06
-$249.00K
derived: sum of 4 quarters · filed 2018-08-06
2017-03-31$364.00K
10-Q · filed 2018-05-15
$231.00K
derived: sum of 2 quarters · filed 2018-05-15
$309.00K
derived: sum of 3 quarters · filed 2018-05-15
$883.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$133.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$55.00K
derived: sum of 2 quarters · filed 2018-03-08
$519.00K
derived: sum of 3 quarters · filed 2018-03-08
$1.51M
10-K · filed 2018-03-08
2016-09-30$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$652.00K
derived: sum of 2 quarters · filed 2017-11-14
$1.65M
10-Q · filed 2017-11-14
$1.83M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$574.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$1.57M
10-Q · filed 2017-08-10
$1.75M
derived: sum of 3 quarters · filed 2017-08-10
$2.48M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$996.00K
10-Q · filed 2017-05-10
$1.18M
derived: sum of 2 quarters · filed 2017-05-10
$1.90M
derived: sum of 3 quarters · filed 2017-05-10
$1.92M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$183.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21
$907.00K
derived: sum of 2 quarters · filed 2017-03-21
$924.00K
derived: sum of 3 quarters · filed 2017-03-21
$1.03M
10-K · filed 2017-03-21
2015-09-30$724.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$741.00K
derived: sum of 2 quarters · filed 2016-11-14
$845.00K
10-Q · filed 2016-11-14
$818.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$17.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$121.00K
10-Q · filed 2016-08-15
$94.00K
derived: sum of 3 quarters · filed 2016-08-15
$148.00K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$104.00K
10-Q · filed 2016-05-12
$77.00K
derived: sum of 2 quarters · filed 2016-05-12
$131.00K
derived: sum of 3 quarters · filed 2016-05-12
$304.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23
$27.00K
derived: sum of 2 quarters · filed 2016-03-23
$200.00K
derived: sum of 3 quarters · filed 2016-03-23
$345.00K
10-K · filed 2016-03-23
$345.36K
10-K · filed 2015-03-12
2014-09-30$54.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$227.00K
derived: sum of 2 quarters · filed 2015-11-12
$372.00K
10-Q · filed 2015-11-12
$372.21K
10-Q · filed 2014-11-12
-$97.36K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$173.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$318.00K
10-Q · filed 2015-08-12
$318.13K
10-Q · filed 2014-08-13
-$151.36K
derived: sum of 3 quarters · filed 2015-08-12
-$205.78K
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$145.00K
10-Q · filed 2015-05-13
$145.18K
10-Q · filed 2014-05-15
-$324.36K
derived: sum of 2 quarters · filed 2015-05-13
-$378.79K
derived: sum of 3 quarters · filed 2015-05-13
-$160.21K
derived: sum of 4 quarters · filed 2015-05-13
$557.21K
10-Q · filed 2014-05-15
2013-12-31-$469.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$523.78K
derived: sum of 2 quarters · filed 2015-03-12
-$305.21K
derived: sum of 3 quarters · filed 2015-03-12
-$239.80K
10-K · filed 2015-03-12
$412.03K
10-K · filed 2014-03-28
2013-09-30-$54.42K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$164.15K
derived: sum of 2 quarters · filed 2014-11-12
$229.56K
10-Q · filed 2014-11-12
$399.63K
derived: sum of 4 quarters · filed 2014-11-12
$769.52K
10-Q · filed 2013-11-06
2013-06-30$218.57K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13
$283.99K
10-Q · filed 2014-08-13
$283.98K
10-Q · filed 2013-08-14
$454.05K
derived: sum of 3 quarters · filed 2014-08-13
$398.26K
derived: sum of 4 quarters · filed 2014-08-13
$823.95K
10-Q · filed 2013-08-14
2013-03-31$65.41K
10-Q · filed 2014-05-15
$235.47K
derived: sum of 2 quarters · filed 2014-05-15
$179.69K
derived: sum of 3 quarters · filed 2014-05-15
$258.75K
derived: sum of 4 quarters · filed 2014-05-15
$605.37K
10-Q · filed 2013-05-08
2012-12-31$170.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$114.28K
derived: sum of 2 quarters · filed 2014-03-28
$193.34K
derived: sum of 3 quarters · filed 2014-03-28
$231.44K
10-K · filed 2014-03-28
$539.96K
10-K · filed 2013-03-18
2012-09-30-$55.78K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$23.27K
derived: sum of 2 quarters · filed 2013-11-06
$61.37K
10-Q · filed 2013-11-06
$101.57K
derived: sum of 4 quarters · filed 2013-11-06
$369.90K
10-Q · filed 2012-11-14
2012-06-30$79.06K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$117.16K
10-Q · filed 2013-08-14
$157.36K
derived: sum of 3 quarters · filed 2013-08-14
$159.71K
derived: sum of 4 quarters · filed 2013-08-14
$425.68K
10-Q · filed 2012-08-14
2012-03-31$38.10K
10-Q · filed 2013-05-08
$78.30K
derived: sum of 2 quarters · filed 2013-05-08
$80.65K
derived: sum of 3 quarters · filed 2013-05-08
2011-12-31$40.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$42.55K
derived: sum of 2 quarters · filed 2013-03-18
$144.98K
10-K · filed 2013-03-18
2011-09-30$2.35K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$104.78K
10-Q · filed 2012-11-14
2011-06-30$102.43K
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B